Romany Johnpulle - Concepedia

Author

Romany Johnpulle

Vanderbilt University Medical Center

Also Known As

Romany A. Johnpulle, Romany A. N. Johnpulle, Romany A.N. Johnpulle, Romany Anne Nilanthi Johnpulle, Romany Johnpulle

Publications

627

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Medical Center University of Alabama at Birmingham Dana-Farber Cancer Institute Melanoma Institute Australia The University of Sydney

About

Romany Johnpulle is an author at Vanderbilt University Medical Center specializing in cancer research, tumor biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	43
2	Immunology	2	2	43
3	Cell Biology	1	1	17
4	Diabetes	1	1	17
5	Metabolism	1	1	17

Romany Johnpulle

Publications

586

Citations

H-Index

Page 1

	Year	Citations
Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma Allison Betof Warner, Ryan David Nipp, Anita Giobbie‐Hurder, The Oncologist	2017	201
Sequencing Treatment in BRAF V600 Mutant Melanoma: Anti-PD-1 Before and After BRAF Inhibition Douglas B. Johnson, Eirini Pectasides, Emily Feld, Journal of Immunotherapy	2016	99
Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling Peter J. Siska, Romany Johnpulle, Alice Y. Zhou, OncoImmunology	2017	82
Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction Bridgette A. Kanz, Megan H. Pollack, Romany Johnpulle, Journal for ImmunoTherapy of Cancer	2016	74
The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced Melanoma Daniel Wang, Jennifer L. McQuade, Raghunath Rajat, The Oncologist	2019	53
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti‐PD‐1 antibodies Inês Pires da Silva, Isabella C. Glitza, Lauren E. Haydu, Pigment Cell & Melanoma Research	2019	34
Responses to immune checkpoint inhibitors in nonagenarians Romany Johnpulle, Robert M. Conry, Jeffrey A. Sosman, OncoImmunology Elderly PatientsImmunologyImmunotherapeuticsImmunotherapyTumor Biology	2016	26
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling Romany Johnpulle, Sophie Paczesny, Dae Kwang Jung, Biology of Blood and Marrow Transplantation Chemoprevention StrategyMetabolic DisorderImmunologySst2 LevelsPathology	2016	17

Page 1